Aethlon Medical, Inc.Financials
|
|
Historical Financials
DEC 2026 | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | 574,245 | 294,165 | 659,104 | 650,187 | 229,625 | 149,625 | 392,073 | |
| Gross Profit Margin (%) | - | - | - | - | - | - | - | - | - | - | |
| R&D Expense | 1,912,000 | 2,212,000 | 2,520,000 | 2,745,000 | 2,341,000 | 2,072,000 | 927,000 | 896,000 | 586,000 | 673,000 |
Sign up to view full financial statements
Create a free CapEdge account to access balance sheet, cash flow, and complete historical data.
DEC 2026 | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | |||||||||||
| Total Operating Expenses | |||||||||||
| Operating Income or Loss | |||||||||||
| Operating Margin (%) | |||||||||||
| EBITDA | |||||||||||
| Interest Expense | |||||||||||
| Non-Operating Income/Expense | |||||||||||
| Income Before Tax | |||||||||||
| Income Tax Expense | |||||||||||
| Income from Continuing Ops. | |||||||||||
| Net Income | |||||||||||
| Net Profit Margin (%) | |||||||||||
| Basic EPS | |||||||||||
| Diluted EPS | |||||||||||
| Basic Average Shares | |||||||||||
| Diluted Average Shares |
All numbers in thousands. Financial statements are in beta and sourced from EDGAR XBRL filings. Read the caveats.